Fiximac-CV consist of a third-generation cephalosporin antibiotic and a beta-lactamase inhibitor used to treat various bacterial infections caused by gram-positive and negative bacteria.
Route of Administration
Oral
Composition
Each film-coated tablet contains:
Cefixime IP as a trihydrate equivalent to Anhydrous Cefixime 200 mg
Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid 125 mg
Excipients q.s.
Indications
Fiximac-CV tablets is indicated for the treatment of a wide range of bacterial infections targeting the Upper respiratory tract, Lower respiratory tract and Urinary tract.
Storage
Protect from light and store below 30°C.
Precautions
Use with caution in patients with a history of penicillin hypersensitivity due to possible cross-reactivity. Dose adjustment may be needed in patients with renal impairment. Prolonged use may result in overgrowth of non-susceptible organisms, including fungi. Use cautiously in patients with a history of gastrointestinal disease, particularly colitis.
